Physical Activity: Clinical Trials

9 trials for Physical Activity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 9
Phase 23Completed 3

Follow Physical Activity: new trials by email Literature Review of Physical Activity trials Research Report on Physical Activity

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neighborhood Park Youth Sports Program Fee Waiver and Intensive Family Outreach
Experimental: Fee Waiver, Fee Waiver Plus Intensive Outreach - Physical Activity
Phase 3CompletedUniversity of Minnesota4302022-02-152026-01-14
Using Social Incentives and Gamification for Weight Loss Promotion
Gamification, Share Data with PCP, Feedback on weight - Weight Loss, Obesity
Phase 3CompletedUniversity of Pennsylvania1962016-01-012016-12-21
The Physical Activity Loyalty Card Scheme
Non-cash incentives, Self-monitoring physical activity levels - Health Behavior, Physical Activity
Phase 2 / Phase 3CompletedQueen's University, Belfast4062011-03-012012-04-11
Reducing Beverages and Sugar and Increasing Physical Activity in Public School Adolescents From Brazil
lifestyle - Sugar Intake, Beverage Intake
Phase 3CompletedRio de Janeiro State University6002010-02-012011-07-20
Practice-based Trial of Blood Pressure Control in African Americans
Therapeutic Lifestyle Changes (MINT-TLC), Usual Care - Hypertension, Physical Activity
Phase 3CompletedNYU Langone Health1942010-02-012013-11-13
Effects of Exercise Training and AGE-crosslink Breaker on Cardiovascular Structure and Function
Alt-711, Physical exercise training - Cardiovascular Disease, Aging
Phase 2 / Phase 3CompletedRadboud University Medical Center482008-11-012013-09-09
Internet-based Physical Activity Intervention
website assess - Physical Activity
Phase 3CompletedUniversity of Southern Denmark122872008-05-012011-02-14
Physical Activity in Women With Infants
physical activity tailored, physical activity standard - Physical Activity
Phase 3CompletedUniversity of Hawaii3112008-04-012015-06-04
Promoting Physical Activity Among Patients With Type 2 Diabetes
print-based physical activity intervention, usual care - Type 2 Diabetes, Physical Activity
Phase 2 / Phase 3CompletedFlorida State University852006-04-012015-03-06

Narrower conditions

Motor Activity (9)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Health Behavior (1)  ·  Hypertension (1)  ·  Medication Adherence (1)  ·  Obesity (1)  ·  Weight Loss (1)

Broader conditions

Behavior (9)  ·  Nutritional and Metabolic Diseases (2)  ·  Body Weight (1)  ·  Body Weight Changes (1)  ·  Cardiovascular Diseases (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Health Behavior (1)  ·  Metabolic Diseases (1)  ·  Nutrition Disorders (1)  ·  Overnutrition (1)  ·  Overweight (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Patient Acceptance of Health Care (1)  ·  Patient Compliance (1)

Interventions

Exercise (1)  ·  alagebrium (1)

Sponsors

Florida State University (1)  ·  NYU Langone Health (1)  ·  Queen's University, Belfast (1)  ·  Radboud University Medical Center (1)  ·  Rio de Janeiro State University (1)  ·  University of Hawaii (1)  ·  University of Minnesota (1)  ·  University of Pennsylvania (1)  ·  University of Southern Denmark (1)

Countries

United States (4)  ·  Brazil (1)  ·  Denmark (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Andreas Wolff Hansen, Msc. (1)  ·  Cheryl L Albright, PhD, MPH (1)  ·  Frank Kee (1)  ·  Gareth Dutton, PhD (1)  ·  Gbenga G Ogedegbe, M.D. (1)  ·  Maria TE Hopman, MD, PhD (1)  ·  Mitesh Patel, MD, MBA, MS (1)  ·  Simone A French, PhD (1)

Results publications

PMID 22192273, PMID 22533900, PMID 23111127, PMID 23451237, PMID 24400341, PMID 25402618, PMID 26135553, PMID 33293392, PMID 40402087

NIH funding

R01CA115614 (1)